Capitalises on increasing amounts of data from multiple sources and the growing demand for evidence-based decision-making that leverages real-world data
At OKRA.ai, we use AI to leverage real-world data to provide a better understanding of patient population, clinical differentiation, societal burden and health-related quality of life associated with innovative treatments to inform positioning and launch strategies.
Life science industry clients can leverage AI to estimate the burden of a treatment on patients, caregivers and society as a whole.
With the RWE solution, it is possible to integrate disparate data sources and establish if treatment would potentially be able to alleviate societal and disease burdens for patients.
RWE solution can identify the appropriate target patient population to be able to provide evidence on clinical differentiating factors to the current standard of care. Providing a better view of the eligibility of patients for treatments when critical prognostic variables are not available.
Let us walk you through our solutions and how they can offer help to your team.
Contact the AI Experts